Carreras(J) Biomedicines 2026-05-17

...CASP8, TNFAIP8, LMO2, MYC, MDM2, CDK6, and TP53 markers at a quantitative level. Conclusions: The DLBCL overall survival...

Gao(N),Yu(FX) Invest Ophthalmol Vis Sci 2026-05-01

...Casp8 upregulation was blunted, whereas RIPK3 upregulation was enhanced. At the tissue level, cleaved caspase-3 (c-Casp3...

Deebani(AO),Anwar(KMA),Anwar(YMA),Alsahafi(S… 3 Biotech 2026-09-00

...CASP8, CASP9) while downregulating the anti-apoptotic gene BCL2, supporting a shift toward programmed cell death. Cell c...

Zou(J),Tian(X),Sun(Y),Wang(S) Curr Issues Mol Biol 2026-08-14

...CASP8 and VEGFA met Tier A external criteria, whereas ADRB2 and SLC6A2 met Tier B criteria. At the stricter |log2FC| ≥ 0...

Carreras(J),Kikuti(YY),Nagase(S),Roncador(G)… Cancers (Basel) 2026-07-15

...CASP8, MYOB, TP53, cPARP, cCASP3, ISY1, TNFAIP8, CSF1R, CD163, PD-L1 and IL-10 markers. Gene expression analysis using t...

Zhu(Y),Wang(Z),Li(C),Shi(L),Liu(W) Oral Oncol 2026-08-10

...CASP8, and CYP2B6) mutational panel for risk stratification (any mutation vs. no mutation) of OLK malignant transformati...

Cornejo Müller(A),Liehr(T),Balakrishnan(P),K… Cells 2026-07-24

...Casp8 and Nemo alleles, allowing for efficient Cre-mediated deletion to generate Casp8ΔNemoΔ derivatives. Loss of both C...

Grassi(C),Bondi(M),Albanese(G),Zerbi(A),Ucce… J Mol Endocrinol 2026-08-19

...CASP8) was investigated pharmacologically using the preferential CASP8 inhibitor Z-IETD-FMK, alone or in combination wit...

Cortez Cardoso Penha(R),Virani(S),Holt(JR),Z… J Natl Cancer Inst 2026-08-13

...CASP8 mutations compared to tumors from ever smoker-ever drinkers (N = 353). Together, these findings define distinct, e...

Su(Y),Huang(H),Qin(H) Biochem Biophys Res Commun 2026-08-13

...CASP8, TNF, SIRT1, MAPK3, MAPK1, TLR4, NLRP3, MLKL, HMGB1) were identified, mainly enriched in necroptosis, TNF signalin...